精神症状的颅内神经生物标志物及其指导神经调控治疗的效用:系统综述
该系统综述汇总了将颅内神经活动与行为及症状维度相关联的近期研究,涵盖医院环境与自然环境下植入式神经调控设备的记录。文章识别了不同记录策略与环境间共有的神经行为关系,并探讨了利用这些信息指导神经调控治疗(尤其是闭环或临床医生在环策略)的潜在方式,强调需考虑疾病特异性的时间常数。
要点
- 颅内神经生物标志物可反映精神症状维度的神经生理基础,并可能指导神经调控治疗。
- 植入式设备支持在自然环境中长期记录颅内神经活动,拓展了神经行为关系的研究场景。
- 闭环刺激策略需考虑疾病特异性的时间常数,即神经标志物变化与症状行为变化之间的时滞关系。
核心结论
- 颅内神经生物标志物与精神症状维度相关,有望用于指导神经调控治疗。
- 闭环或临床医生在环的神经调控策略需考虑疾病特异性的时间常数。
研究设计与样本
- 系统综述,汇总将颅内神经活动与行为及症状相关联的近期研究,涵盖医院环境与自然环境下植入式设备记录。
主要发现
- 不同记录策略与环境间存在共有的神经行为关系。
- 植入式神经调控设备可同时刺激并记录颅内神经活动,支持在自然环境中长期记录。
临床怎么用
- 可利用颅内神经生物标志物指导神经调控治疗,探索闭环或临床医生在环的实施方式。
- 设计闭环策略时需考虑神经标志物变化与症状行为变化之间的疾病特异性时间常数。
局限性
- 原文未明确报告系统综述的检索范围、纳入研究数量及具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The quest to develop and improve neuromodulatory therapies for treatment-resistant psychiatric disorders has been fueled by the discovery of intracranial neural biomarkers of symptom dimensions. These neural correlates shed light on the underlying neurophysiology of the disorder and may even be useful in guiding therapy delivery. This systematic review summarizes recent efforts in this field relating neural activity to behavior and symptomatology. For years, most of these neurobehavioral relationships were studied in the hospital or clinic environment. Recent technological advances in implanted neuromodulation devices that permit not only stimulation but also intracranial neural recording have enabled this research to move into natural settings and record for longer periods of time in the real world. We review this combined literature to identify neurobehavioral relationships that show commonalities across these different recording strategies and environments. We also discuss potential ways to use this information for guiding neuromodulation therapy. The success of closed-loop stimulation strategies for movement disorders and epilepsy has led to interest in exploring similar approaches for psychiatric disorders. However, such efforts need to consider the disorder-specific time constant relating changes in a neural biomarker to changes in symptoms and behavior. This relationship likely differs between Parkinson's disease and depression, obsessive-compulsive disorder, or addiction. We interpret the results of our systematic review in this light to offer suggestions for future closed-loop or clinician-in-the-loop implementations to inform the next generation of neuromodulatory therapies.
引用
- Kabotyanski KE, Provenza NR, Sheth SA, et al. Intracranial Neural Biomarkers of Psychiatric Symptoms and Their Utility for Guiding Neuromodulation Therapy: A Systematic Review. Biol Psychiatry. 2025. PMID: 41093090. doi:10.1016/j.biopsych.2025.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。